HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells
about
Role of endoplasmic reticulum stress in drug-induced toxicityProtective effects of alanyl-glutamine supplementation against nelfinavir-induced epithelial impairment in IEC-6 cells and in mouse intestinal mucosa.Evaluation of HIV protease and nucleoside reverse transcriptase inhibitors on proliferation, necrosis, apoptosis in intestinal epithelial cells and electrolyte and water transport and epithelial barrier function in mice.Noninfectious Diarrhea in HIV Seropositive Individuals: a Review of Prevalence Rates, Etiology, and Management in the Era of Combination Antiretroviral TherapyHIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.Development of a novel self-microemulsifying drug delivery system for reducing HIV protease inhibitor-induced intestinal epithelial barrier dysfunctionPrevention of HIV protease inhibitor-induced dysregulation of hepatic lipid metabolism by raltegravir via endoplasmic reticulum stress signaling pathways.Misfolded proteins: from little villains to little helpers in the fight against cancer.Biomarkers of immune dysfunction in HIV.Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individualsHIV protease inhibitors in gut barrier dysfunction and liver injury.HIV protease inhibitors disrupt lipid metabolism by activating endoplasmic reticulum stress and inhibiting autophagy activity in adipocytesHuman Immunodeficiency Virus-Associated Diarrhea: Still an Issue in the Era of Antiretroviral Therapy.Reduction of the HIV protease inhibitor-induced ER stress and inflammatory response by raltegravir in macrophages.HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress.Plasma Micronutrient Concentrations Are Altered by Antiretroviral Therapy and Lipid-Based Nutrient Supplements in Lactating HIV-Infected Malawian Women.Intestinal Alkaline Phosphatase in Stool: A Novel Biomarker for Metabolic Diseases.The role of CCAAT enhancer-binding protein homologous protein in human immunodeficiency virus protease-inhibitor-induced hepatic lipotoxicity in mice.Association of cyclin D and estrogen receptor α36 with hepatocellular adenomas of female mice under chronic endoplasmic reticulum stress.The unfolded protein response and gastrointestinal diseaseER stress and the unfolded protein response in intestinal inflammation.Endoplasmic reticulum stress: implications for inflammatory bowel disease pathogenesis.Endoplasmic-reticulum calcium depletion and disease.The unfolded protein response triggered by environmental factors.Approach and management of patients with chronic hepatitis B and C during the course of inflammatory bowel disease.Crofelemer for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy.In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals.HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation.Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats.CHOP-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury.Non-Hematopoietic MLKL Protects Against Salmonella Mucosal Infection by Enhancing Inflammasome Activation.
P2860
Q26765518-87CD62AE-501E-4149-ADDB-775356360D09Q30415997-51F1456A-A894-435C-9E27-951C20C3CE57Q30434864-8F8B290F-46DA-4743-A7C5-2D4EB4382450Q30609066-79E6A56E-C4FF-4BD7-B023-0FE53FA6C3A3Q33729269-BE014927-F9EA-4B29-9BB5-575B8544C554Q33901061-B27A3D26-EA0C-4B13-BC8B-D076CFC407EEQ34035275-92AA3A94-1916-4BF6-A95A-9D1FC3345ACCQ34466592-0C15D418-0165-48A7-A98A-16E76EB63D08Q34546742-A5200DF7-7B2B-40C9-A3D5-A4F7F969B083Q34612385-8C674D88-B0E9-4045-B68B-B9D68985E454Q34617496-1B2EF1B9-AD31-412A-99A0-ED0166E51F29Q34637857-5798C420-FFAC-4752-B58C-C39AB0CF749BQ34668617-C73B6E8E-2909-47FB-B6ED-031AE47E3F85Q35119834-366E9432-D951-4AFD-91C5-630868152942Q35620220-5E186126-E336-4E46-A0FF-E0EDDC44F2EDQ35894292-31EE9F43-F494-41E8-9764-2048E0B4B755Q36437773-7B8E65EB-457E-4D79-880A-5F03134E796DQ36592437-EBB8FAD4-E5C4-47D2-B664-D7F8C562F721Q36644420-D8E412E3-7048-4CC9-AFFE-D86742A2B826Q36866561-4535430D-8C04-4409-B9D5-920667BCBC17Q37719188-0F5C4351-8DCC-4284-AD0E-C91D320D001AQ37760005-566F3366-CD55-4573-AFE7-13505357C206Q37858336-FDF4C641-45F7-48EC-9D97-89B4A7508240Q38095787-0C92EC77-0AF7-4A86-80FC-765561CC146BQ38235053-47959382-D194-41BE-8FA8-AD0A98345D19Q38620255-D2459E24-E1AB-4A3A-AEC3-DCA2CE0995B9Q38645161-8D69491E-D82E-4401-B9D7-F3DA0559F5FCQ40404098-8B52E97B-1F36-4A69-9E7D-23FA11531192Q42697966-D4DCCFAD-F511-4FE4-93A8-85CE30354718Q45067747-5C5773DF-3DCF-4C5B-A548-082EE7A5EDB4Q49884899-A729A71E-66A2-45DA-896C-C3FC35465A2B
P2860
HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
HIV protease inhibitors induce ...... in intestinal epithelial cells
@ast
HIV protease inhibitors induce ...... in intestinal epithelial cells
@en
type
label
HIV protease inhibitors induce ...... in intestinal epithelial cells
@ast
HIV protease inhibitors induce ...... in intestinal epithelial cells
@en
prefLabel
HIV protease inhibitors induce ...... in intestinal epithelial cells
@ast
HIV protease inhibitors induce ...... in intestinal epithelial cells
@en
P2093
P2860
P1433
P1476
HIV protease inhibitors induce ...... in intestinal epithelial cells
@en
P2093
Arun J Sanyal
Elaine Studer
Emily Gurley
Guangji Wang
Huiping Zhou
Jian-Ying Wang
Luyong Zhang
P2860
P304
P356
10.1053/J.GASTRO.2009.08.054
P407
P577
2009-09-02T00:00:00Z